This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
CUH2A was fortunate to be the AE firm for this project, participating in the selection and design process. A review of that process will explain the goals particular to Pfizer’s work, the other factors which led to VAV diffusers, and why fintube perimeter heat was featured in the final design. We should also mention that when CUH2A began this project, we had no prior experience designing an entire project with VAV diffusers. CUH2A had used them in conference rooms, and had no predisposition toward them.
When a study is completed, the teams are disbanded and the members assigned to new study teams. This requires relocating them into the office grouping for the new study. As a result, individual offices periodically change occupants.